Navigation Links
Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
Date:6/25/2009

bronchiectasis trial, 64 adult patients were randomized 2:1 to two doses -- either 280 mg or 560 mg of ARIKACE or placebo for 28 days followed by a 28-day off-treatment observation period. Sixteen clinical sites throughout Europe and India are participating in the bronchiectasis study.

ARIKACE has been granted orphan drug status in the United States by the FDA, and has received an orphan drug designation in Europe by the European Medicines Agency for the treatment of Pseudomonas infections in patients with CF.

About The Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation, the leading organization in the United States devoted to curing and controlling cystic fibrosis, has invested more than $320 million in drug research with biotech companies since 1998 to develop therapies to fight CF. As a result, the Foundation has built a drug pipeline with more than 30 promising therapies in development. Virtually every approved CF therapy available today was made possible because of the support of the Foundation. Based in Bethesda, MD, the Foundation has 80 chapters and branch offices, and supports and accredits a nationwide network of 110 CF care centers that provide treatment and vital resources to patients and families. For more information, visit www.cff.org.

About PARI Pharma and the eFlow(R) Nebulizer System

ARIKACE is delivered by an eFlow Nebulizer System developed by PARI Pharma GmbH. The eFlow Nebulizer System uses eFlow Technology to enable highly efficient aerosolization of medication including liposomal formulations via a vibrating, perforated membrane that includes thousands of laser drilled holes. Compared to other nebulization technologies, eFlow Technology produces aerosols with a very high density of active drug, a precisely defined droplet size, and a high prop
'/>"/>

SOURCE Transave, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) is proud ... Vision, Innovation, and Leadership has been awarded to Stuart ... an individual who has had a significant impact on the ... several decades. "I am honored to receive the ... Ph.D., CEO of PTC Therapeutics, Inc. "When I founded PTC ...
(Date:11/21/2014)... Ohio and MELVILLE, N.Y. ... CAH ), one of the world,s largest ... HSIC ), the world,s largest provider of ... health and medical practitioners, today announced that the companies ... one of the most comprehensive service and product offerings ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... , Chief Executive Officer, will be presenting at the 26 ... York Palace Hotel in New York . ... at 2:00 PM ET. In addition, Mr. Krakauer and ... for separate one-on-one meetings during the day. ...
Breaking Medicine Technology:PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5
(Date:11/21/2014)... 21, 2014 The Ohio Children’s Trust ... Ohio Chapter, American Academy of Pediatrics (Ohio AAP, ... education to parents and caregivers throughout Ohio. The new ... 30, 2015, provides $75,000 to continue the campaign that ... Trust Fund is excited to continue partnering with the ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 Recently, ... and launched a wedding dress promotion for the coming ... enjoy a special offer when checking out. , The ... in 2014. The customers like the designs for the ... VogueQueen.com would not only be good for the environment, ...
(Date:11/21/2014)... In summer, when it’s hot out, ... perspire and rarely feel thirsty. As a result, less ... glasses of fresh water a day recommended for health ... Sharon Kleyne. Winter weather is often more dehydrating than ... important.     , The syndicated Sharon Kleyne ...
(Date:11/21/2014)... Recently, DressVe.com , a renowned women’s dress wholesaler ... collection of fashion accessories. Furthermore, the company has launched its ... off, on all its fashion items. Also, orders above $59 ... of the company, their wedding dresses and prom dresses are ... greatly discounted rates. , The CEO says “We are ...
(Date:11/21/2014)... 21, 2014 Even with years of experience ... learn and room for growth, participating in two recent events ... Farm’s National Convention, a networking event with the leaders of ... bringing back the latest and greatest in insurance news and ... Kirk and his team (Stacy, Anthony, Reina and Jacob) as ...
Breaking Medicine News(10 mins):Health News:Ohio AAP and Ohio Children’s Trust Fund Continue Partnership for Safe Sleep Education Campaign 2Health News:Ohio AAP and Ohio Children’s Trust Fund Continue Partnership for Safe Sleep Education Campaign 3Health News:Beach Wedding Dresses on Sale for the Coming Holiday Season at VogueQueen.com 2Health News:Our Bodies Need Eight Glasses of Water a Day Even in Winter Reports Fresh Water Advocate 2Health News:Our Bodies Need Eight Glasses of Water a Day Even in Winter Reports Fresh Water Advocate 3Health News:DressVe.com Announces Its 2014 Special Friday Sales 2Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2
... adjustments to desks, chairs reduce eyestrain, poor posture, study ... a proactive approach can help reduce the level of ... have found. , Employers shouldn,t just assume that problems ... equipment including desks and chairs. It,s also important to ...
... New ... while replacing undefined media components such as hydrolysates or fetal bovine serum ("FBS") in ... ... performance of its newest CHO cell culture media supplement Zap-CHO during the ...
... Inc., a medical device company that develops technologies for ... that the first procedure in Spain utilizing its cPAX ... CE Mark earlier this year. , Dr. Alfredo Casasco, ... Nuestra Senora del Rosario, used 143cm of cPAX in ...
... , KidzPartners now available in Philadelphia County ... that it is offering comprehensive health insurance through the ... you by Health Partners, newest program, KidzPartners, has already ... to surrounding counties in the future. , ...
... ... & Drug Administration (FDA) approval of its biologics license application (BLA) for the first 15 ... it has entered into an exclusive agreement with the MED Alliance Group, Inc. (MAGI) to ... ...
... China, Oct. 28 /PRNewswire-Asia-FirstCall/ -- China Pharma,Holdings, Inc. ("China Pharma") ... pharmaceutical products in China, today,announced that it plans to release ... the market opens. , The Company ... November 12, 2009,to discuss fiscal third quarter 2009 results. ...
Cached Medicine News:Health News:Takes a Pro to Make Offices Pain-Free 2Health News:InVitria Reports Successful Cell Culture Performance of Zap-CHO, a Defined and Cost Effective CHO Cell Culture Media Supplement 2Health News:NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 2Health News:NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 3Health News:Health Partners to Offer Health Insurance Through the Children's Health Insurance Program 2Health News:Quotient Biodiagnostics Signs MED Alliance Group, Inc. as Exclusive Distributor in Midwest for Line of Transfusion Diagnostics 2Health News:Quotient Biodiagnostics Signs MED Alliance Group, Inc. as Exclusive Distributor in Midwest for Line of Transfusion Diagnostics 3Health News:China Pharma Holdings, Inc. to Report Third Quarter 2009 Financial Results on November 12, 2009 2
The new, single-use 26 mL applicator is latex-free, hands-off and sterile to help prevent cross-contamination. The applicator is designed for a smooth delivery of the solution for larger surgical pro...
... Performance Panel consists of plasma specimens with ... for antibodies to the Hepatitis C Virus. ... manufacturers and diagnostic laboratories to evaluate their ... test systems are included for comparative analysis ...
Comprised of a monofilament polypropylene mesh coated with hydrophilic porcine collagen, Pelvitex™ mesh is clinically proven coating to enhance the healing process, along with the strength and d...
... a biological material derived from ... for excellent suppleness and strength. ... ensure high levels of quality ... enhances the biocompatibility, performance and ...
Medicine Products: